Biotech News
Senseonics Holdings, Inc. Reports Third Quarter 2026 Financial Results
Senseonics Holdings, Inc. (NASDAQ: SENS), a diabetes company redefining continuous glucose monitoring (CGM) with long-term implantable sensing technology, today announced third quarter 2026 financial results and provided a business update.
